MedTrace Logo

Effects of Aromatase Inhibitor Therapy on Muscle Function

NCT03581552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2021-05-10

No results posted yet for this study

Summary

This is a pilot study designed to examine changes in muscle function after Aromatase Inhibitor (AI) therapy, at both the molecular and clinical level.

Conditions

Sponsors & Collaborators

  • Tarah J Ballinger, MD

    lead OTHER

Principal Investigators

  • Tarah Ballinger, MD · Indiana University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-26
Primary Completion
2020-02-07
Completion
2020-02-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581552 on ClinicalTrials.gov